Vincerx Pharma, Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.08-$18.70 |
Market Cap | $3.9M |
Shares Short | 137,204 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$15.85 |
News
See moreYahoo Finance • 6 days ago
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
Yahoo Finance • 15 days ago
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
Yahoo Finance • last month
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
Yahoo Finance • 2 months ago
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
About
CEO | Dr. Raquel E. Izumi Ph.D. |
CFO | Mr. Kevin Haas |
Address | 1825 S. Grant Street, San Mateo, CA, United States, 94402 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
